Last edition
News about "Fennec Pharmaceuticals"
The U.S. FDA has accepted Fennec Pharmaceuticals resubmitted new drug application (NDA) for Pedmark, a drug aimed at preventing hearing loss in children who receive platinum-based chemothera
Fennec Pharmaceuticals | 30/04/2022 | By Sudeep Soparkar | 596
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members